ZENTMAN SAMUEL M 4

What Happened

• Samuel M. Zentman, a director of Klotho Neurosciences (KLTO), received a grant of 350,000 shares on 2026-03-04. The Form 4 reports the transaction as an award/grant (code A); no purchase price or total dollar value is provided in the filing.

Key Details

• Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (timely filing — two days after the transaction).
• Shares granted: 350,000. Price per share / total value: N/A — not disclosed in the filing.
• Shares owned after the transaction: Not specified in the reported information.
• Footnote: The shares were granted under the company’s Equity Incentive Plan (per footnote F1).
• No indication in the filing of tax withholding, vesting schedule, or immediate sale — those details are not disclosed.

Context

• Grants under an equity incentive plan are common compensation for directors and employees; they do not represent an open-market purchase or sale. Such awards can be subject to vesting, transfer restrictions, or other conditions not detailed in this Form 4, so the grant alone should not be taken as a direct buy/sell signal.